Back

Prognostic value of secondary cardiac alterations in patients with moderate aortic valve stenosis

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Valvular heart disease and infective endocarditis e-posters Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Stephan Stoebe

University hospital Leipzig AoR, Leipzig (Germany)

130 More presentations in this session

Presentation thumbnail
Clinical and echocardiographic characteristics associated with the development of infective endocarditis in patients with significant mitral stenosis
Doctor N. Ngiam (Singapore, SG)
Abstract Slides
Presentation thumbnail
Local or general anesthesia for TAVI surgery? An updated systematic review and meta-analysis.
Doctor Z. Cheng (Chengdu, CN)
Abstract Slides
Presentation thumbnail
Use of left ventricular support devices during transcatheter aortic valve replacement and balloon aortic valvuloplasty: a single center experience
Doctor S. Mahmood (Detroit, US)
Abstract Slides
Presentation thumbnail
Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Impact of mitral valve regurgitation severity on clinical outcomes in patients with severe aortic stenosis undergoing TAVI
Doctor V. Jimenez Franco (San Pedro Garza Garcia, MX)
Abstract Slides

Access the full session

Session thumbnail
Valvular heart disease and infective endocarditis e-posters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of the presence and extension valvular-related cardiac damage in patients with moderate aortic stenosis and its impact on outcomes
11 December 2024
thumbnail
Congress Presentation
Comparison of the predictive role of changes in left ventricular mass and arterial stiffness for coronary artery disease in essential hypertension: Data from a 8-year-follow-up study
3 September 2019
thumbnail
Congress Presentation
Prognostic value of cardiopulmonary exercise testing in valvular heart disease
27 August 2021
thumbnail
Congress Presentation
Prognostic significance of multi-modality congestion assessment in acute heart failure according to left ventricular ejection fraction
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources